Test Price
450 AED✅ Home Collection Available
CK-5/6 Immunohistochemistry (IHC) Test in Dubai, UAE | 450 AED | DHA Licensed
Executive Summary & Core Metrics
Executive Summary: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Secure Medical Courier Solid Tissue Specimen Retrieval (ISO-Certified Chain of Custody) – Archival tissue retrieval from hospital pathology departments.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-registered oncology specialists.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The CK-5/6 Immunohistochemistry (IHC) Test detects basal cytokeratin expression in tumor tissue, essential for classifying triple-negative and basal-like breast cancers. This high-specificity assay uses validated anti-CK5/6 monoclonal antibodies on formalin-fixed, paraffin-embedded (FFPE) tissue blocks or freshly fixed surgical specimens, delivering actionable subtyping results within 7 days.
| Feature | Our CK-5/6 IHC Test | Closest Alternative (Generic IHC) |
|---|---|---|
| Diagnostic Precision | 99.9% sensitivity for basal keratin 5/6 | May lack CK-5/6 monoclonal antibody specificity |
| Methodology | Immunohistochemistry (IHC) with validated anti-CK5/6 clones | General IHC without dedicated basal marker panel |
| Turnaround Speed | FFPE block: 5 days; large complex tissue: 7 days | Often >10 days due to send-out workflows |
Physician Insight & Safety Protocols
Mr. Prabhakar Reddy Kalathoor | Specialist Diagnostic Radiology | DHA Registration ID: 61713011 “CK-5/6 immunohistochemistry is essential for identifying basal-like breast cancers and refining therapeutic strategies. This marker must always be correlated with full histopathological assessment and clinical imaging. I advise patients to discuss their results with their treating oncologist for personalized management before any treatment changes.”
Medication Advisory
Do not discontinue prescribed medication without consulting your doctor. Changing treatment based solely on test results can be life-threatening. Please consult your managing oncologist for interpretation of this IHC result.
Safety & Exclusion Criteria
- Do not undergo this test if you have an active, untreated bleeding disorder at the biopsy site.
- ER Red Flags: seek immediate medical attention if you experience excessive bleeding, fever, or signs of infection after biopsy collection.
- This test is not validated for cytology specimens; only FFPE blocks or freshly fixed tissue are accepted.
- Minors require signed guardian consent as per UAE Federal Decree-Law No. 4 of 2016 on Medical Liability and UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL).
Patient FAQ & Clinical Guidance
1. What is the CK-5/6 test used for and why is it important for breast cancer?
CK-5/6 identifies basal-like breast cancers, refining prognosis and predicting chemotherapy response in aggressive tumours. It is a cornerstone for triple-negative breast cancer subtyping and helps differentiate basal-like carcinomas from other epithelial malignancies. Your oncologist will use this data alongside hormone receptor status to design a tailored treatment regimen.
2. How should I prepare for a CK-5/6 tissue biopsy and what does the process involve?
Submit tumor tissue in 10% formal-saline or a paraffin block with a histopathology report. A surgeon or interventional radiologist will obtain the biopsy; then the sample is fixed and transported at room temperature via our certified chain-of-custody logistics. You must provide a copy of the prior histopathology report, exact biopsy site, and full clinical history to ensure accurate correlation.
3. How long does it take to get results and are they accurate?
Results are delivered within 5 days for standard blocks, backed by 99.9% diagnostic sensitivity. Our ISO 9001:2015 certified laboratory uses validated anti-CK5/6 monoclonal antibodies and digital pathology review for maximum accuracy. Urgent requests can be expedited—contact our support team via WhatsApp at +971 54 548 8731 for same-day dispatch coordination.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance & Data Privacy
DNA Labs UAE strictly adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient data is encrypted, access-controlled, and processed exclusively within the UAE. Our laboratory holds DHA Facility License No. 1143, ensuring compliance with Dubai Healthcare City Authority standards.
Clinical safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | CK-5/6 Immunohistochemistry (IHC) Test |
| Price (AED) | 450 AED |
| Turnaround Time | 5–7 business days (standard FFPE block: 5 days; complex tissue: 7 days) |
| Sample Type / Matrix | Archival Tissue Specimen (FFPE Block or Freshly Fixed Tissue) |
| Methodology Used | Immunohistochemistry (IHC) with validated anti-CK-5/6 monoclonal antibodies |
| ICD-10-CM Code | C50.9 (Malignant neoplasm of breast, unspecified) |
| LOINC Code | 21942-3 (Cytokeratin 5/6 [Presence] in Tissue by Immunohistochemistry) |
| DHA Facility License & Laboratory Address | DNA Labs UAE, DHA License No. 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians